Multinational pharma giant Johnson and Johnson along with Telangana-based Biological E. Limited will manufacture the Johnson & Johnson COVID-19 vaccine, which could boost the country's overall supplies amid a shortage.
In a statement, Johnson & Johnson said, "We're working around clock to develop & broadly activate manufacturing capabilities to supply vaccine worldwide."
In April, Johnson and Johnson had applied to India's drug regulator seeking permission to conduct phase-3 clinical trial of its single-dose COVID-19 vaccine in India as well as import licence.
ALSO READ: Pfizer, Moderna, Johnson and Johnson vaccines effective against B1617 variant of COVID-19